Drugs / bivalent oral polio vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04504539 | Aug 2020 → May 2021 | — | Aga Khan University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bivalent oral polio vaccine | “bOPV (bivalent oral polio vaccine) is an oral polio vaccines which consists of attenuated virus of serotypes 1and 3” NCT04504539 ↗ |
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04504539 ↗ |
| Modality | Vaccine | “bOPV (bivalent oral polio vaccine) is an oral polio vaccines which consists of attenuated virus of serotypes 1and 3” NCT04504539 ↗ |
| Route | Oral | “bOPV (bivalent oral polio vaccine) is an oral polio vaccines” NCT04504539 ↗ |